Attachment B - Federal Register Notice - 60 Day

Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices
Rights, 200 Independence Ave. SW.,
Room 509F, Washington, DC 20201.
NOTIFICATION PROCEDURE:

Contact System Manager (above).
Include name and address of
complainant, and name of the recipient
against which the allegation was filed.
The Department is exempting all
investigative records from this provision
(see below: Records Exempted).
RECORD ACCESS PROCEDURE:

Same as notification procedures.
Requesters should also reasonably
specify the record contents being
sought. Requests should be made to the
system manager (above). The
Department is exempting all
investigative records from this provision
(see below: Records Exempted).
CONTESTING RECORD PROCEDURE:

Contact the official(s) at the address
specified under System Manager, and
reasonably identify the record and
specify the information to be contested
and corrective action sought with
supporting justification. (These
procedures are in accordance with
Department Regulations (45 CFR 5b.7)
Federal Register, October 8, 1975, page
47411.) The Department is exempting
all investigative records from this
provision (see below: Records
Exempted).
RECORD SOURCE CATEGORIES:

Information is provided by
complainants and covered entities.
SYSTEM RECORDS EXEMPTED FROM CERTAIN
PROVISIONS OF THE ACT:

OCR investigative records maintained
in PIMS, either as paper records or
electronic documents are records
compiled for law enforcement purposes
are exempt under subsection (k)(2) from
the notification, access, correction and
amendment provisions of the Privacy
Act.

cprice-sewell on PROD1PC62 with NOTICES

APPENDIX NUMBER 1—SYSTEM LOCATIONS:

This system is located at HHS offices
in the following cities.
Headquarters, PIMS Project Manager,
Resource Management Division,
Office for Civil Rights, 200
Independence Ave., SW., Room 509F,
Washington, DC 20201.
Region I, Regional Manager, OCR/HHS,
J.F. Kennedy Federal Building—Room
1875 Boston, Massachusetts 02203.
Region II, Regional Manager, OCR/HHS,
26 Federal Plaza—Suite 3312, New
York, NY 10278.
Region III, Regional Manager, OCR/
HHS, 150 S. Independence Mall West,
Suite 372, Public Ledger Building,
Philadelphia, PA 19106.

VerDate Aug<31>2005

15:22 Feb 26, 2007

Jkt 211001

Region IV, Regional Manager, OCR/
HHS, Atlanta Federal Center, Suite
3B70, 61 Forsyth Street, SW., Atlanta,
GA 30303.
Region V, Regional Manager, OCR/HHS,
233 N. Michigan Ave, Suite 240,
Chicago, IL 60601.
Region VI, Regional Manager, OCR/
HHS, 1301 Young Street, Suite 1169,
Dallas, TX 75202.
Region VII, Regional Manager, OCR/
HHS, 601 E. 12th Street—Room 248,
Kansas City, MO 64106.
Region VIII, Regional Manager, OCR/
HHS, Federal Office Building, 1961
Stout Street—Room 1185, Denver, CO
80294.
Region IX, Regional Manager, OCR/
HHS, 50 United Nations Plaza—Room
322, San Francisco, CA 94102.
Region X, Regional Manager, OCR/HHS,
2201 Sixth Avenue—Suite 900,
Seattle, WA 98121.
[FR Doc. E7–3283 Filed 2–26–07; 8:45 am]
BILLING CODE 4153–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–07–05CZ]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Joan Karr, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques

PO 00000

Frm 00060

Fmt 4703

Sfmt 4703

8737

or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Assessing Diabetes Detection
Initiative for Policy Decision—New—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Type 2 diabetes is a chronic disease
that affects more than 18 million
Americans, approximately 5 million of
whom do not know that they have the
disease. As the disease progresses, it
often causes severe complications,
including heart disease, blindness,
lower extremity arterial disease, and
kidney failure. American Indians,
African Americans, Latino Americans,
and some Asian Americans and Pacific
Islanders are disproportionately affected
by diabetes. Identifying persons who
have undiagnosed diabetes and treating
them could prevent or delay diabetes
complications.
In November 2003 the Diabetes
Detection Initiative (DDI) was launched
in 10 locations around the U.S. to
identify a portion of the estimated 5
million people with undiagnosed Type
2 diabetes, targeting specific areas in
each of 10 locales in which residents are
likely to be at higher risk for Type 2
diabetes. Implementation of the DDI
involved distributing a paper-and-pencil
risk test. Individuals whose score
indicated that they were at an increased
risk for diabetes were advised to see
their regular doctor (or to schedule an
appointment at one of several clinics
that had agreed to participate in the
DDI), to receive a finger-stick or other
tests to confirm whether or not they
have diabetes. Whether or not the DDI
should be expanded to other
communities depends on the health
benefits and costs of the program. The
CDC is planning to conduct a study to
provide this critical information.
The planned study will assess the
resources used, the cost per case
detected, and the perceived benefit of
the DDI to participants. Data for the
economic assessment will be obtained
by conducting three separate surveys:
(1) A local implementation team survey
will be administered to the 10 DDI local
implementation leaders to obtain
information on resources used by the
members of DDI local implementation
teams and community based
organizations to implement the nonmedical service delivery activities for
the DDI program; (2) a health clinic

E:\FR\FM\27FEN1.SGM

27FEN1

8738

Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices

leadership survey will be sent to the
clinic directors in each of the 43 clinics
that participated in the DDI across the
10 locations to obtain information on
the cost of delivering the medical
services required in diabetes screening
and diagnosis; and (3) a patient survey
will be administered to a sample of 600
patients at the 43 participating clinics to
obtain information regarding patient
out-of-pocket medical and non-medical
direct health care costs and the
perceived economic benefits of diabetes
screening. The results of the study will
also provide information needed for
conducting a more complete costeffectiveness analysis of screening for
undiagnosed diabetes.
The local implementation team
survey will be mailed to the local DDI
implementation team leader in each of
the 10 regions to collect information
regarding the staff time and other

resources used to implement the DDI
program (including the staff time and
resources used by community-based
organizations that participated in the
DDI implementation). These planning
and implementation activities include
participating in meetings and
conference calls, recruiting clinics and
community-based organizations to
participate in the DDI, distributing risk
tests, organizing health fairs and other
community events, and designing media
campaigns to promote the DDI.
The health clinic leadership survey
will be mailed to the clinic director at
each of the 43 clinics across the 10
locations that participated in the DDI
implementation. The survey will collect
information regarding the costs
associated with the clinic’s participation
in the DDI. These will include the
medical costs of providing care to
patients who visited the clinic as a

result of the DDI, staff time associated
with DDI planning and implementation,
and any staff time that was devoted to
performing finger stick tests at locations
other than the health clinic (e.g., health
fairs, shopping malls, work sites,
housing complexes). Of the 43 clinics to
be surveyed, we expect that 30 (70%)
will complete the survey.
A computer-assisted in-person patient
survey will be administered to a sample
of 600 clinic patients at the 43 clinics
that participated in the DDI. The survey
will collect background information,
out-of-pocket medical and non-medical
direct health care costs (e.g., copayments, transportation costs, value of
patients’ time associated with the clinic
visit), and preferred features of a
diabetes screening program. There are
no costs to respondents other than their
time.

ESTIMATED ANNUALIZED BURDEN HOURS
No. of
respondents

Respondents

Average
burden per
response
(in hours)

Total
burden
(in hours)

Implementation team members ...........................................................................
Clinic staff ............................................................................................................
Patients at DDI clinics .........................................................................................

10
30
600

1
1
1

2
1
20/60

20
30
200

Total ..............................................................................................................

........................

........................

........................

250

Dated: February 22, 2007.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–3333 Filed 2–26–07; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–07–07AJ]

Proposed Data Collections Submitted
for Public Comment and
Recommendations

cprice-sewell on PROD1PC62 with NOTICES

No. of
responses per
respondent

In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Joan Karr, CDC

VerDate Aug<31>2005

15:22 Feb 26, 2007

Jkt 211001

Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Racial and Ethnic Approaches to
Community Health across the U.S.
(REACH US) Management Information
System (MIS)—New—National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).

PO 00000

Frm 00061

Fmt 4703

Sfmt 4703

Background and Brief Description
Racial and Ethnic Approaches to
Community Health (REACH) currently
funds forty local coalitions to establish
community based programs and
culturally appropriate interventions to
eliminate racial and ethnic health
disparities. Communities served by
REACH include: African American,
American Indian, Hispanic American,
Asian American, and Pacific Islander.
These communities select among infant
mortality, deficits in breast and cervical
cancer screening and management,
cardiovascular diseases, diabetes, HIV/
AIDS, and deficits in childhood and
adult immunizations to focus their
interventions. Guided by logic models,
each community articulates goals,
objectives, and related activities; tracks
whether goals and objectives are met,
ongoing, or revised; and evaluates all
program activities. This information
will then be entered into the REACH
Management Information System
(REACH MIS). REACH MIS is a
customized internet-based support
system that allows REACH grantees to
perform remote data entry and retrieval
of data. The contract for our current
Information Network (REACH IN), OMB

E:\FR\FM\27FEN1.SGM

27FEN1